(Q44242461)

1 December 2017

Tenofovir treatment at 30 mg/kg/day can inhibit cortical bone mineralization in growing rhesus monkeys (Macaca mulatta). (English)

1 reference

1 December 2017

0 references

1 reference

Alesha B Castillo

1

1 reference

1 December 2017

Alice F Tarantal

series ordinal

2

1 reference

1 December 2017

Mitchell R Watnik

series ordinal

3

1 reference

1 December 2017

R Bruce Martin

series ordinal

4

1 reference

1 December 2017

1 November 2002

1 reference

Journal of Orthopaedic Research

1 December 2017

1 reference

1 December 2017

20

1 reference

1 December 2017

6

1 reference

1 December 2017

1185-1189

1 reference

Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2802%2900074-8

Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2802%2900074-8

Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2802%2900074-8

Metabolic complications associated with antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2802%2900074-8

Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): safety and efficacy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2802%2900074-8

Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2802%2900074-8

Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2802%2900074-8

Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2802%2900074-8

Alterations to the en bloc basic fuchsin staining protocol for the demonstration of microdamage produced in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2802%2900074-8

7 January 2021

Microdamage adjacent to endosseous implants

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2802%2900074-8

7 January 2021

Osteopenia in HIV-infected patients: is it the disease or is it the treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2802%2900074-8

7 January 2021

Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2802%2900074-8

7 January 2021

Bone mineral content in girls perinatally infected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2802%2900074-8

7 January 2021

Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2802%2900074-8

7 January 2021

Effects of (R)-9-(2-phosphonylmethoxypropyl)adenine monotherapy on chronic SIV infection in macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2802%2900074-8

7 January 2021

The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2802%2900074-8

7 January 2021

10.1016/S0736-0266(02)00074-8

Identifiers

DOI

1 reference

1 December 2017

1 reference